Cell & Bioscience (Dec 2023)

Precision nephrotoxicity testing using 3D in vitro models

  • Pengfei Yu,
  • Hainan Zhu,
  • Carol Christine Bosholm,
  • Daniella Beiner,
  • Zhongping Duan,
  • Avinash K. Shetty,
  • Steve S. Mou,
  • Philip Adam Kramer,
  • Luis F. Barroso,
  • Hongbing Liu,
  • Kun Cheng,
  • Michael Ihnat,
  • Matthew A. Gorris,
  • Joseph A. Aloi,
  • Jobira A. Woldemichael,
  • Anthony Bleyer,
  • Yuanyuan Zhang

DOI
https://doi.org/10.1186/s13578-023-01187-0
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Nephrotoxicity is a significant concern during the development of new drugs or when assessing the safety of chemicals in consumer products. Traditional methods for testing nephrotoxicity involve animal models or 2D in vitro cell cultures, the latter of which lack the complexity and functionality of the human kidney. 3D in vitro models are created by culturing human primary kidney cells derived from urine in a 3D microenvironment that mimics the fluid shear stresses of the kidney. Thus, 3D in vitro models provide more accurate and reliable predictions of human nephrotoxicity compared to existing 2D models. In this review, we focus on precision nephrotoxicity testing using 3D in vitro models with human autologous urine-derived kidney cells as a promising approach for evaluating drug safety.

Keywords